Ifm Investors Pty LTD Nektar Therapeutics Transaction History

Ifm Investors Pty LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 13, 2020	SELL	$15.87 - $23.12 $235,558 - $343,170	-14,843 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$16.91 - $36.27 $79,882 - $171,339	4,724 Added 46.68%	14,843 $270,000
Q4 2018 Jan 23, 2019	BUY	$30.43 - $56.65 $29,699 - $55,290	976 Added 10.67%	10,119 $333,000
Q3 2018 Oct 22, 2018	BUY	$46.46 - $68.49 $92,176 - $135,884	1,984 Added 27.71%	9,143 $557,000
Q2 2018 Jul 09, 2018	BUY	$46.25 - $104.45 $331,103 - $747,757	7,159 New	7,159 $350,000

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Ifm Investors Pty LTD with notifications on news.